Growth hormone treatment improves body composition in adults with Prader-Willi syndrome

Clinical Endocrinology

Volumn 58, Issue 5, 2003, Pages 653-661

  Höybye, Charlotte ^a   Hilding, Agneta ^a   Jacobsson, Hans ^a   Thorén, Marja ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; HUMAN GROWTH HORMONE;

ABSORPTIOMETRY; ADULT; AGE; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; FEMALE; GENOTYPE; HUMAN; LEAN BODY WEIGHT; MALE; METABOLISM; ORAL GLUCOSE TOLERANCE TEST; PRADER WILLI SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WATER RETENTION; X RAY ANALYSIS;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENOTYPE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; METHYLATION; PRADER-WILLI SYNDROME; WEIGHT GAIN;

EID: 0037656509     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01769.x     Document Type: Article

References (35)

1. Albareda, M., Rodrigues-Espinosa, J., Murugo, M., de Leiva, A. & Corcoy, R. (2000) Assesment of insulin sensitivity and beta cell function from measurements in the fasting state and during an oral glucose tolerence test. Diabetologia, 43, 1507-1511.
2. l'Allemand, D., Eiholzer, U., Schlumpf, M., Steinert, H. & Riesen, W. (2000) Cardiovascular risk factors improve under 3 years of growth hormone therapy in Prader-Willi syndrome. European Journal of Pediatrics, 159, 835-842.
3. Bang, P., Wivall, I.L., Eriksson, U., Sara, V & Hall, K. (1991) Comparison of acid-ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: Improvement of determination in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinologica, 107, 563-570.
4. Bengtsson, B.-Å., Abs, R., Bennmarker, H., Monson, J.P., Feldt-Rasmussen, U., Hernberg-Ståhl, E., Westberg, B., Wilton, P. & Wuster, C. (1999) The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 84, 3929-3935.
5. Binnerts, A., Swart, G.R., Wilson, J.H.P., Hoogerbrugge, N., Pois, H.A.P., Birkenhager, J.C. & Lamberts, S.W. (1992) The effect of growth hormone administration in growth hormone-deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clinical Endocrinology, 37, 79-87.
6. Bonora, E., Kiechl, S., Willeit, J., Obenhollenzer, F., Egger, G., Targher, G., Alberiche, M., Bonadonna, R.C. & Muggeo, M. (1998) Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes, 47, 1643-1649.
7. Bosio, L., Beccaria, L., Benzi, F., Sanzari, A. & Chiumello, G. (1999) Body composition during GH treatment in Prader-Willi syndrome. Journal of Pediatric Endocrinology and Metabolism, 12, 351-353.
8. Carel, A.L., Myers, S.E., Whitman, B.Y. & Allen, D.B. (1999) Growth hormone improves body composition, fat utilisation, physical strength and agility and growth in Prader-Willi syndrome: a controlled study. Journal of Pediatrics, 134, 215-221.
9. Caroll, P.V. & Christ, E.R. and the members of Growth Hormone Research Society Scintific Committee. (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism, 83, 382-395.
10. Cassidy, S. (1997) Prader-Willi syndrome. Journal of Medical Genetics, 34, 917-923.
11. Chotai, K.A. & Payne, S.J. (1998) A rapid, PCR-based test for differential molecular diagnosis of Prader-Willi and Angelman syndromes. Journal of Medical Genetics, 35, 472-475.
12. Clasey, J.L., Kanaley, J.A., Wideman, S., Heimsfield, S.B., Teates, C.D., Gutgesell, M.E., Thorner, M.O., Hartman, M.L. & Weltman, A. (1999) Validity of methods of body composition assessment in young and older men and women. Journal of Applied Physiology, 86, 1728-1738.
13. Eiholzer, U., Bachrnan, S. & l'Allemand, D. (2000) Is there growth hormone deficiency in Prader-Willi syndrome? Hormone Research, 53 (Suppl.), 44-52.
14. Friedewald, W.T., Levy, R.L. & Fredrickson, D.S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clinical Chemistry, 18, 499-502.
15. Goldstone, A.P., Thomas, E.L., Brynes, A.E., Bell, J.D., Frost, G., Saeed, N., Hajnal, J.V., Howard, J.K., Holland, A. & Bloom, S.R. (2001) Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. Journal of Clininical Endocrinology and Metabolism, 86, 4330-4338.
16. Growth Hormone Research Society (1998) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 379-381.
17. Herman-Bonert, V.S., Prager, D. & Melmed, S. (1995) Growth Hormone and Metabolism: The Pituitary. Cambridge, Massachusetts: Blackwell Science.
18. Hilding, A., Hall, K., Wivall-Helleryd, I.L., Sääf, M., Melin, A.L. & Thorén, M. (1999) Serum levels of insulin-like growth factor-1 in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. Journal of Clinical Endocrinology and Metabolism, 84, 2013-2019.
19. Holm, V.A., Cassidy, S.B., Butler, M.G., Hanchett, J.M., Greenswag, L.R., Whitman, B.Y. & Greenberg, F. (1993) Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics, 91, 398-401.
20. Höybye, C., Hilding, A., Jacobsson, H. & Thorén, M. (2002) Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity. Journal of Clinical Endocrinology and Metabolism, 87, 3590-3597.
21. Jeffcoate, W. (2002) Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence. Drug Safety, 25, 199-212.
22. Johannsson, G., Rosén, T & Bengtsson, B.A. (1997) Individualized dose titration of growth hormone (GH) replacement in hypopituitary adults. Clinical Endocrinology, 47, 571-581.
23. Jorgensen, J.O.L., Pedersen, S.A., Thuesen, L., Jorgensen, J., Ingeman-Hansen, T., Skakkebaeck, N.E. & Christiansen, J.S. (1989) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, 1, 1221-1224.
24. Ledbetter, D.H., Riccardi, V.M., Airhart, S.D., Strobel, R.J., Keenan, S.B. & Crawford, J.D. (1981) Deletions of chromosome 15 as a cause of the Prader Willi syndrome. New England Journal of Medicine, 304, 325-329.
25. Lindgren, A.C., Grandell, U., Ritzén, E.M. & Anvret, M. (1996) Diagnosis of the Prader-Willi syndrome by proving the absence of unmethylated PW71 DNA fragment. Acta Paediatrica, 85, 195-198.
26. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
27. Myers, S.E., Davis, A., Withman, B.Y., Santiago, J.V. & Landt, M. (2000) Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement. Clinical Endocrinology, 52, 101-105.
28. Póvoa, G., Roovete, A. & Hall, K. (1984) Cross-reaction of somatomedin-binding protein a radioimmunoassay developed for somatomedin-binding protein isolated from human anmiotic fluid. Acta Endocrinologica, 107, 563-570.
29. Prader, A., Labhart, A. & Willi, H. (1956) Ein Syndrom von Adipositas Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartgen Zustand im Neugeborenalter. Schweizerische Mediziniche Wochenschrift, 86, 1260-1261.
30. Rosenfalck, A.M., Maghsoudi, S., Fisker, S., Jorgensen, J.O.L., Christiansen, J.S., Hilsted, J., Volund, A.A. & Madsbad, S. (2000) The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 85, 4173-4181.
31. Scuster, D.P., Osei, K. & Zipf, W.B. (1999) Characterisation of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism, 45, 1514-1520.
32. Solomon, F., Cuneo, R.C., Hesp, R. & Sönksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1729-1803.
33. Tothill, P., Avenell, A., Love, J. & Reid, D.M. (1994) Comparisons between Hologic, Lunar and Norland dual X-ray absorptiometers and other techniques used for whole-body soft-tissue measurements. European Journal of Clinical Nutrition, 48, 781-794.
34. WHO Expert Comittee (1980) Diabetes Mellitus: Second Report. WHO Technical Report Series 646. Geneva: WHO.
35. Zipf, W.B. (1999) Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy. Acta Paediatrica, 443 (Suppl.), 115-117.